tiprankstipranks
Thermo Fisher (GB:0R0H)
LSE:0R0H

Thermo Fisher (0R0H) Share Price & Analysis

3 Followers

0R0H Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$416.09 - $602.74
Previous Close$573.08
Volume229.00
Average Volume (3M)21.53K
Market Cap
$218.95B
Enterprise Value$245.90B
Total Cash (Recent Filing)$8.08B
Total Debt (Recent Filing)$34.92B
Price to Earnings (P/E)36.8
Beta0.99
Jul 24, 2024
Dividend Yield0.25%
Share Statistics
EPS (TTM)15.59
Shares Outstanding381,312,268
10 Day Avg. Volume9,105
30 Day Avg. Volume21,530
Standard Deviation0.06
R-Squared0.08
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)-15.67
Price to Sales (P/S)4.64
Price to Cash Flow (P/CF)14.70
P/FCF Ratio14.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.74
Enterprise Value/Gross Profit8.28
Enterprise Value/Ebitda35.58
Forecast
Price Target Upside8.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering17

Bulls Say, Bears Say

Bulls Say
Financial PerformanceThermo Fisher Scientific reported solid quarterly results with higher than expected margins and earnings per share, indicating a robust financial health.
Market PositionWith industry consolidation offering potential opportunities, Thermo Fisher Scientific is poised to strengthen its market position through strategic acquisitions and partnerships.
Product DemandDemand for Analytical Instruments, particularly electron microscopy, is on the rise, showcasing strong product performance and market growth potential.
Bears Say
Company ValuationValuation front shows significant recent multiple expansion, with EPS forecast for 2025 below consensus.
Earnings GuidanceInvestors are somewhat disappointed in TMO's initial 2024 guide, which reflects a slightly lower mid-point for core growth and EPS than previously indicated.
Financial PerformanceLife Sciences Solutions (LSS) was weaker, down 12% versus expectations.
---

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.48%26.70%19.76%53.06%
19.76% Other Institutional Investors
53.06% Public Companies and
Individual Investors

0R0H FAQ

What was Thermo Fisher’s price range in the past 12 months?
Thermo Fisher lowest share price was $416.09 and its highest was $602.74 in the past 12 months.
    What is Thermo Fisher’s market cap?
    Currently, no data Available
    When is Thermo Fisher’s upcoming earnings report date?
    Thermo Fisher’s upcoming earnings report date is Jul 24, 2024 which is in 86 days.
      How were Thermo Fisher’s earnings last quarter?
      Thermo Fisher released its earnings results on Apr 24, 2024. The company reported $5.11 earnings per share for the quarter, beating the consensus estimate of $4.709 by $0.401.
        Is Thermo Fisher overvalued?
        According to Wall Street analysts Thermo Fisher’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Thermo Fisher pay dividends?
          Thermo Fisher pays a Quarterly dividend of $0.39 which represents an annual dividend yield of 0.25%. See more information on Thermo Fisher dividends here
            What is Thermo Fisher’s EPS estimate?
            Thermo Fisher’s EPS estimate is $5.12.
              How many shares outstanding does Thermo Fisher have?
              Thermo Fisher has 381,713,870 shares outstanding.
                What happened to Thermo Fisher’s price movement after its last earnings report?
                Thermo Fisher reported an EPS of $5.11 in its last earnings report, beating expectations of $4.709. Following the earnings report the stock price went down -0.097%.
                  Which hedge fund is a major shareholder of Thermo Fisher?
                  Among the largest hedge funds holding Thermo Fisher’s share is Tci Fund Management Ltd. It holds Thermo Fisher’s shares valued at 2B.
                    ---

                    Company Description

                    Thermo Fisher

                    Thermo Fisher Scientific, Inc. provides analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services segments. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
                    ---

                    0R0H Company Deck

                    ---

                    0R0H Earnings Call

                    Q1 2024
                    0:00 / 0:00
                    ---

                    0R0H Revenue Breakdown

                    53.76%53.76%23.28%16.95%10.28%
                    53.76% Laboratory Products and Biopharma Services
                    23.28% Life Sciences Solutions
                    16.95% Analytical Instruments
                    10.28% Specialty Diagnostics
                    tipranks
                    ---

                    0R0H Stock 12 Months Forecast

                    Average Price Target

                    $623.82
                    ▲(8.85% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"plus_tr_sans","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"454":"$454","663":"$663","506.25":"$506.3","558.5":"$558.5","610.75":"$610.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":662,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$662.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":623.82,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$623.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":540,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$540.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[454,506.25,558.5,610.75,663],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Oct<br/>2023","9":"Jan<br/>2024","12":"Apr<br/>2024","25":"Apr<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,587.7938461538462,593.9776923076923,600.1615384615385,606.3453846153847,612.5292307692308,618.7130769230769,624.896923076923,631.0807692307692,637.2646153846154,643.4484615384615,649.6323076923077,655.8161538461538,{"y":662,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,584.8569230769231,588.1038461538461,591.3507692307693,594.5976923076923,597.8446153846154,601.0915384615384,604.3384615384616,607.5853846153847,610.8323076923077,614.0792307692308,617.3261538461539,620.573076923077,{"y":623.82,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,581.61,578.4092307692308,575.2084615384615,572.0076923076923,568.8069230769231,565.6061538461538,562.4053846153846,559.2046153846154,556.0038461538462,552.8030769230769,549.6023076923077,546.4015384615385,543.2007692307692,{"y":540,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":555.276,"date":1682640000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":544.221,"date":1683244800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":520.558,"date":1685664000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":516.055,"date":1688688000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":552.05,"date":1691107200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.868,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":499.45,"date":1696550400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":455.015,"date":1698969600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":495.231,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":531.75,"date":1704412800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":550.488,"date":1706832000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":575.791,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":581.61,"date":1712275200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Thermo Fisher
                    Bio-Rad Laboratories
                    Align Tech
                    Illumina
                    Danaher

                    Best Analysts Covering 0R0H

                    1 Year
                    1 Year Success Rate
                    20/20 ratings generated profit
                    100%
                    1 Year Average Return
                    +23.46%
                    upgraded a buy rating 3 months ago
                    Copying Jack Meehan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.46% per trade.
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis